SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
SEC Accession No. 0001193125-11-331929
Filing Date
2011-12-06
Accepted
2011-12-06 15:00:33
Documents
1
Filing Date Changed
2011-12-06
Effectiveness Date
2011-12-06

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 d265491ds8pos.htm S-8 POS 22435
  Complete submission text file 0001193125-11-331929.txt   23454
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-159439 | Film No.: 111245642
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1